Vol 5, Supplement 7 (December 29, 2016): Translational Cancer Research

Editorial

Urachal carcinoma: towards a precision medicine

Alessia Mennitto, Claudio Vernieri, Giuseppe Procopio

PDF Pages: S1307-S1310 Full Text (5127) COI Form Open Access

Different intellectual outcomes in molecular subgroups of medulloblastoma

Noriyuki Kijima, Yonehiro Kanemura

PDF Pages: S1311-S1314 Full Text (3118) COI Form Open Access

Indolence versus aggression in non-small cell lung cancer: defining heterogeneity to impact clinical outcomes

Brandon S. Grimes, Kostyantyn Krysan, Linh M. Tran, Stacy J. Park, Denise R. Aberle, Avrum E. Spira, Steven M. Dubinett

PDF Pages: S1315-S1319 Full Text (2796) COI Form Open Access

Should optimal supportive care alone be the standard of care for brain metastases patients from non-small cell lung cancer, who are not eligible for radiosurgery or surgery?

May N. Tsao

PDF Pages: S1320-S1322 Full Text (2269) COI Form Open Access

BRAF inhibitors in advanced BRAF-positive non-small cell lung cancer

Tiziana Vavalà

PDF Pages: S1323-S1327 Full Text (3815) COI Form Open Access

Cell intrinsic PD-1 checkpoint blockade releases the brake on human chimeric antigen receptor (CAR) T cells for solid tumors

Joseph A. Fraietta, J. Joseph Melenhorst, Bruce L. Levine

PDF Pages: S1328-S1332 Full Text (4288) COI Form Open Access

Personalized peptide vaccine in prostate cancer: capitalizing on existing immunity

Ravi A. Madan, James L. Gulley

PDF Pages: S1333-S1335 Full Text (1961) COI Form Open Access

“Simplicity is complexity resolved”: the case of postoperative radiation therapy after breast conservation

Pierfrancesco Franco, Gary M. Freedman, Umberto Ricardi, Philip Poortmans

PDF Pages: S1336-S1339 Full Text (2456) COI Form Open Access

Emerging multikinase inhibitors for the treatment of differentiated thyroid cancer: whom to treat?

Jolanta Krajewska, Dagmara Rusinek, Barbara Jarzab

PDF Pages: S1340-S1344 Full Text (2760) Open Access

Routine prophylactic drainage in rectal surgery—closing the chapter?

Martine A. Frouws, Cornelis J. H. van de Velde

PDF Pages: S1345-S1348 Full Text (2886) COI Form Open Access

Tumor treating fields—effective, but at what cost?

Isabella Zhang, Jonathan P. S. Knisely

PDF Pages: S1349-S1353 Full Text (9207) COI Form Open Access

A cytological link between radioresistance and autophagy

Kuan-Chih Chow

PDF Pages: S1354-S1357 Full Text (2858) COI Form Open Access

Hypoxia-induced DNA hypermethylation: another reason to normalize tumor vessels

Mei Rosa Ng, Rakesh K. Jain

PDF Pages: S1358-S1362 Full Text (3622) COI Form Open Access

Relapsed small cell lung cancer: is more better?

Vinicius Ernani, Apar Kishor Ganti

PDF Pages: S1363-S1365 Full Text (5161) COI Form Open Access

JMJD3 histone demethylase—a potential therapeutic target for metastatic hepatocellular carcinoma?

Sai-Kam Li, Yick Pang Ching

PDF Pages: S1366-S1368 Full Text (2755) COI Form Open Access

Is combined chemotherapy with cisplatin, etoposide and irinotecan the new standard treatment for patients with sensitive relapsed small cell lung cancer?

Alessandro Morabito

PDF Pages: S1369-S1371 Full Text (2579) COI Form Open Access

Hypofractionated radiotherapy for breast cancer: how to evaluate chronic toxicity and cosmesis?

Javier Sanz, Nuria Rodríguez, Manuel Algara

PDF Pages: S1372-S1376 Full Text (4002) COI Form Open Access

Sentinel node biopsy in combination with extended pelvic lymph node dissection for men with prostate cancer at risk of nodal involvement

Mauro Gacci, Pietro Spatafora, Sergio Serni

PDF Pages: S1377-S1379 Full Text (2084) COI Form Open Access

Omission of adjuvant radiotherapy in early-stage breast cancer: have we identified a subgroup?

Angela Lin

PDF Pages: S1380-S1382 Full Text (4570) COI Form Open Access

Trunk or branch? Identifying and targeting intratumoral heterogeneity in hepatocellular carcinoma using genomics and patient derived primary cancer cells

Kelsey E. Wuensch, Aik Choon Tan

PDF Pages: S1383-S1386 Full Text (4742) COI Form Open Access

Micropapillary urothelial carcinoma: is molecular hair-splitting on target?

Nuzhat Husain, Azfar Neyaz

PDF Pages: S1387-S1392 Full Text (3226) COI Form Open Access

Distinct benefit from crizotinib in lung cancer patients carrying distinct ALK translocations: is fluorescent hybridization in situ testing still sufficient to guide clinical decisions?

Natalia V. Mitiushkina, Evgeny N. Imyanitov

PDF Pages: S1393-S1395 Full Text (3207) COI Form Open Access

PD-L1 is a diverse molecule regulating both tumor-intrinsic signaling and adaptive immunosuppression

Kim A. Brogden, Shireen Vali, Taher Abbasi

PDF Pages: S1396-S1399 Full Text (6343) Open Access

Transgenic mouse models of Idh-mutated neural stem cells: an appropriate model for low grade glioma?

William Leenders

PDF Pages: S1400-S1403 Full Text (3921) COI Form Open Access

Pelvic drain after colorectal anastomosis: useful or useless

Varut Lohsiriwat

PDF Pages: S1404-S1407 Full Text (6688) COI Form Open Access

A transcriptional-microRNA network for β-catenin-driven stemness in hepatocellular carcinoma

William K.K. Wu, Matthew T.V. Chan, Alfred S.L. Cheng

PDF Pages: S1408-S1412 Full Text (2845) COI Form Open Access

Adding chemotherapy to TKI: can we improve first-line treatment for EGFR-mutated NSCLC patients?

Francesco Passiglia, Antonio Russo

PDF Pages: S1413-S1416 Full Text (3091) COI Form Open Access

Commentary

Predictive biomarkers for prostate brachytherapy—not there yet

Jaimee C. Eckers, Randall J. Kimple

PDF Pages: S1417-S1419 Full Text (2222) COI Form Open Access

PGC1α curtails prostate cancer metastasis via metabolic rewiring

Erica J. McDonald, Vanessa S. Arciero, Urban Emmenegger

PDF Pages: S1420-S1423 Full Text (3090) COI Form Open Access

How far have we achieved by systemic therapy for recurrent/metastatic nasopharyngeal carcinoma?

Victor Lee

PDF Pages: S1424-S1427 Full Text (2260) COI Form Open Access

A new approach to high risk pediatric acute lymphoblastic leukemia?

Diane Hanna, Mary Ann Anderson

PDF Pages: S1428-S1432 Full Text (3424) Open Access

When tumors are (co-)opting to resist anti-angiogenic treatment

Lasse D. Jensen

PDF Pages: S1433-S1436 Full Text (3520) COI Form Open Access

Versikine, a proteolysis product of Versican: novel therapeutics for multiple myeloma

Nidhi Gupta, Raman Kumar, Alpana Sharma

PDF Pages: S1437-S1439 Full Text (3902) COI Form Open Access

The role of long noncoding RNA FOXF1-AS1 as a tumor suppressor in non-small cell lung cancer

Hao Zheng, Aswini R. Krishnan, Angela E. Zou, Weg M. Ongkeko

PDF Pages: S1440-S1442 Full Text (2310) COI Form Open Access

Checkpoints inhibitors in first line therapy of metastatic non-small cell lung cancer patients

Luis E. Raez, Christian Rolfo, Mauricio Mahave, Christian Caglevic

PDF Pages: S1443-S1448 Full Text (3191) Open Access

Trimming the fat in non-small cell lung cancer: a new small molecule inhibitor of acetyl-CoA carboxylase to target fatty acid synthesis

Amanda L. Davis, Steven J. Kridel

PDF Pages: S1449-S1452 Full Text (3405) COI Form Open Access

Repurposing multiple sclerosis drug dimethyl fumarate, a promising fast track candidate for systemic cutaneous T cell lymphoma treatment

Martin Herold, Luisa Klotz

PDF Pages: S1453-S1456 Full Text (3549) Open Access

The Wnt/β-catenin pathway is activated by miR-1246 in liver cancer stem cells

Melanie A. Eshelman, Gregory S. Yochum

PDF Pages: S1457-S1460 Full Text (3445) COI Form Open Access

Targeting B-Raf kinase for thyroid cancer treatment: promise and challenge

Xiulong Xu, Richard A. Prinz

PDF Pages: S1461-S1464 Full Text (3771) COI Form Open Access

Toward the clarification of the role of whole-brain radiation therapy for brain metastases from non-small cell lung cancer: a comment about the QUARTZ trial

Hirotake Saito, Toshimichi Nakano, Miki Shioi, Hidefumi Aoyama

PDF Pages: S1465-S1468 Full Text (2612) COI Form Open Access

Utility of gene expression signature in treatment decision of breast cancer

Seema Thakur, Ankan Mukherjee Das, Bhudev C. Das

PDF Pages: S1469-S1472 Full Text (3068) COI Form Open Access

Major thoracic surgery in patients under antiplatelet therapy

Francesco Cassiano, Cecilia Menna, Claudio Andreetti, Mohsen Ibrahim

PDF Pages: S1473-S1475 Full Text (3531) COI Form Open Access

Empiric H. pylori therapy—10-day concomitant, bismuth quadruple or 14-day triple therapy: none is best

Yoshio Yamaoka, David Y. Graham

PDF Pages: S1476-S1478 Full Text (5497) Open Access

miRNA transported by exosomes: a key machinery in tumor microenvironment mediated chemoresistance

Teresa Gagliano, Thomas Simon, Georgios Giamas

PDF Pages: S1479-S1482 Full Text (2784) COI Form Open Access

Rac1 and EMT: a dangerous liaison?

Javier Vaquero, Laura Fouassier

PDF Pages: S1483-S1485 Full Text (3526) COI Form Open Access

Secreted reporter proteins, a valuable complementary tool for non-invasive preclinical monitoring of brain tumour growth

Ludwig J. Dubois, Frank Verhaegen, Marc A. Vooijs

PDF Pages: S1486-S1488 Full Text (2729) COI Form Open Access

[¹⁸F]-choline PET/CT as an imaging biomarker for primary liver cancers

Zhenghong Lee

PDF Pages: S1489-S1492 Full Text (5860) Open Access

Direct acting antivirals for hepatitis c and hepatocellular carcinoma recurrence: an unsolved mystery

Virginia A. Dines, Michael D. Leise

PDF Pages: S1493-S1495 Full Text (1824) COI Form Open Access

Perspective

Perspective on the regulatory role of UGT2B28 as a conjugating enzyme in the progression of prostate cancer

Therina du Toit, Amanda C. Swart

PDF Pages: S1496-S1502 Full Text (3227) COI Form Open Access

HIF-pathway proteins: central regulators of tumor immunology

Sundary Sormendi, Ben Wielockx

PDF Pages: S1503-S1508 Full Text (2715) Open Access

Small molecule inhibition of speckle-type POZ protein-substrate interactions for the treatment of renal cell carcinoma

Byung Joon Hwang, Yun Kee

PDF Pages: S1509-S1514 Full Text (4242) COI Form Open Access

Tumor intrinsic resistance to anti-programmed death 1

Jacqueline Liu, Ting Fang, Adil I. Daud

PDF Pages: S1515-S1520 Full Text (3413) COI Form Open Access

Transoral endoscopic thyroidectomy: current state of the art—a systematic literature review and results of a bi-center study

Thomas Wilhelm, Guoyang Wu, Afshin Teymoortash, Christian Güldner, Thomas Günzel, Stefan Hoch

PDF Pages: S1521-S1530 Full Text (7541) COI Form Open Access

DNA hypermethylation of tumor suppressor genes as an early lung cancer biomarker

Tomasz Powrózek, Teresa Małecka-Massalska

PDF Pages: S1531-S1538 Full Text (4399) COI Form Open Access

Evolving concepts of micropapillary variant urothelial carcinoma

M. Francesca Monn, Liang Cheng

PDF Pages: S1539-S1542 Full Text (3501) COI Form Open Access

Programmed death ligand 1 expression and human papillomavirus status: penile cancer prognostic factors and new therapeutic opportunities

Kelly L. Stratton, Mohammad Ramadan, Ahmed Eldefrawy, Daniel J. Culkin

PDF Pages: S1543-S1545 Full Text (2220) Open Access

Correspondence

Response letter: “epigenetic modulation of a miR-296-5p:HMGA1 axis regulates Sox2 expression and glioblastoma stem cells”

Hernando Lopez-Bertoni, John Laterra

PDF Pages: S1546-S1548 Full Text (2293) COI Form Open Access

Why observational studies are important in comparative effectiveness research: the effect of breast-conserving therapy and mastectomy in the real world

Marissa C. van Maaren, Philip Poortmans, Luc J. A. Strobbe, Linda de Munck, Sabine Siesling

PDF Pages: S1549-S1550 Full Text (2083) COI Form Open Access

DDR1 and Notch: a multifaceted synergy

Chiara Ambrogio, David Santamaría

PDF Pages: S1551-S1553 Full Text (2216) COI Form Open Access

Response letter: Bronchial sleeve resection or pneumonectomy for non-small cell lung cancer? Pneumonectomy is still a valid choice

Saana Andersson, Ilkka Ilonen, Jarmo A. Salo, Jari Räsänen

PDF Pages: S1554-S1555 Full Text (1860) COI Form Open Access

Disclosure:

This supplement was published without any sponsorship or funding.